Cummings SR, Ettinger B, Delmas PD, Kenemans P, Stathopoulos V, Verweij P, et al. The effects of tibolone in older postmenopausal women. N Engl J Med 2008;359(7):697–708. https://www.ncbi.nlm.nih.gov/pubmed/18703472
Formoso G, Perrone E, Maltoni S, Balduzzi S, Wilkinson J, Basevi V, et al. Short-term and long-term effects of tibolone in postmenopausal women. Cochrane Database Syst Rev 2016;10:CD008536. https://www.ncbi.nlm.nih.gov/pubmed/27733017
Komm BS, Thompson JR, Mirkin S. Cardiovascular safety of conjugated estrogens plus bazedoxifene: meta-analysis of the SMART trials. Climacteric 2015;18(4):503–11. https://www.ncbi.nlm.nih.gov/pubmed/25511453
Mirkin S, Komm BS, Pan K, Chines AA. Effects of bazedoxifene/conjugated estrogens on endometrial safety and bone in postmenopausal women. Climacteric 2013;16(3):338–46. https://www.ncbi.nlm.nih.gov/pubmed/23038989
Palacios S, Stevenson JC, Schaudig K, Lukasiewicz M, Graziottin A. Hormone therapy for first-line management of menopausal symptoms: Practical recommendations. Womens Health (Lond) 2019;15:1745506519864009. https://www.ncbi.nlm.nih.gov/pubmed/31378196
